Atland S.A. (ATLD.PA) stock: key figures, P/E, revenue and dividend
Real Estate · Diversified REITs · France
Price
31.30 EUR
Market cap
135.43 m EUR
P/E (2025)
16.71
P/S (2025)
0.78
Dividend yield
5.59 %
Net margin
4.65 %
Return on equity (ROE)
5.89 %
Return on assets (ROA)
2.06 %
Atland S.A. financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 198.94 m EUR | 174.14 m EUR |
| Gross profit | 65.70 m EUR | 67.65 m EUR |
| Operating income | 21.22 m EUR | 12.04 m EUR |
| EBIT | 24.25 m EUR | 12.93 m EUR |
| Net income | 8.81 m EUR | 8.11 m EUR |
| Diluted EPS – continuing operations | 2.03 EUR | 1.87 EUR |
Full history since 2007, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Atland S.A.
Fonciere Atland operates as a real estate investment trust. It invests in offices, retail outlets, warehouses, or light industrial premises. It also provides real estate sale-leaseback services, and construction and turnkey rental development services to business customers. The company is based in Paris, France.
More stocks
- Torimbia Socimi S.A. (YTRM.MC)
- Alpha Technology Group Limited Ordinary Shares (ATGL)
- Bjorn Borg AB (BORG.ST)
- Carnaby Resources Ltd (CNB.AX)
- MACROGENICS INC (MGNX)
- Fong Chien Construction Co Ltd (5523.TWO)
- UTime Limited (FXHO)
- Fu Yu Property Co Ltd (4907.TWO)
- Sajo Ind (007160.KS)
- Mirai Semiconductors Co., Ltd. (254490.KQ)
- Wafangdian Bearing Co Ltd (200706.SZ)
- Mycenax Biotech (4726.TWO)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.